Description
Identification of new markers and molecular targets for the treatment of pulmonary fibrosis. Identification of molecular determinants of fibroblast-myofibroblast transition using omics technologies. Role of inflammation and stroma in the tumour microenvironment and lung cancer progression.
Keywords
fibrosis, myofibroblast, cancer, stroma, inflammation,
Frascati classification
